tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RARE Stock Latest News

Ultragenyx to present GTX-102 Angelman syndrome program update
The FlyUltragenyx to present GTX-102 Angelman syndrome program update
1d ago
RARE
Ultragenyx to Present GTX-102 Angelman Syndrome Program Update at the ASF Family Conference and Research Symposium
PremiumPress Releases
Ultragenyx to Present GTX-102 Angelman Syndrome Program Update at the ASF Family Conference and Research Symposium
1d ago
RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
6d ago
RARE
Ultragenyx announces end-of-Phase 2 meeting with FDA for GTX-102
PremiumThe Fly
Ultragenyx announces end-of-Phase 2 meeting with FDA for GTX-102
8d ago
RARE
Ultragenyx Shareholders Approve Directors and Incentive Plans
PremiumCompany Announcements
Ultragenyx Shareholders Approve Directors and Incentive Plans
1M ago
8K
RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesUltragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
1M ago
RARE
Mereo BioPharma price target raised to $8 from $6 at Leerink
PremiumThe Fly
Mereo BioPharma price target raised to $8 from $6 at Leerink
1M ago
MREO
RARE
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
RNA
AXSM
Ultragenyx 7.44M share Secondary priced at $39.00
PremiumThe Fly
Ultragenyx 7.44M share Secondary priced at $39.00
1M ago
RARE
Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
PremiumPress Releases
Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
1M ago
RARE
Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
PremiumPress Releases
Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
1M ago
RARE
Ultragenyx announces $350M common stock, warrants offering
PremiumThe Fly
Ultragenyx announces $350M common stock, warrants offering
1M ago
RARE
Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA)
PremiumPress ReleasesUltragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA)
1M ago
RARE
Ultragenyx plans to file for accelerated approval of UX111
PremiumThe Fly
Ultragenyx plans to file for accelerated approval of UX111
1M ago
RARE
Ultragenyx and Mereo announce results from Phase 2/3 Orbit study
PremiumThe Fly
Ultragenyx and Mereo announce results from Phase 2/3 Orbit study
1M ago
MREO
RARE
Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)
PremiumPress Releases
Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)
1M ago
RARE
JPMorgan biotech analysts hold an analyst/industry conference call
PremiumThe Fly
JPMorgan biotech analysts hold an analyst/industry conference call
2M ago
IONS
RARE
Ultragenyx upgraded to Buy from Neutral at Goldman Sachs
PremiumThe Fly
Ultragenyx upgraded to Buy from Neutral at Goldman Sachs
2M ago
RARE
Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference
PremiumPress Releases
Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference
2M ago
RARE
Ultragenyx price target raised to $83 from $81 at Barclays
PremiumThe FlyUltragenyx price target raised to $83 from $81 at Barclays
2M ago
RARE
Ultragenyx price target lowered to $76 from $83 at BofA
PremiumThe Fly
Ultragenyx price target lowered to $76 from $83 at BofA
2M ago
RARE
Ultragenyx price target raised to $127 from $124 at Stifel
PremiumThe Fly
Ultragenyx price target raised to $127 from $124 at Stifel
2M ago
RARE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >